masoprocol and Weight Gain

masoprocol has been researched along with Weight Gain in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Azain, MJ; Hargrave-Barnes, KM; Miner, JL	1
Hwang, JK; Jo, K; Kim, D; Lee, MS	1

Other Studies

2 other study(ies) available for masoprocol and Weight Gain

Article	Year
Conjugated linoleic acid-induced fat loss dependence on Delta6-desaturase or cyclooxygenase. Obesity (Silver Spring, Md.), 2008, Volume: 16, Issue:10 Topics: Adipose Tissue; Adiposity; Animals; Aspirin; Cyclooxygenase Inhibitors; Dietary Fats; Dinoprostone; Eating; Enzyme Inhibitors; Leukotriene B4; Linoleic Acids, Conjugated; Linoleoyl-CoA Desaturase; Lipoxygenase; Lipoxygenase Inhibitors; Liver; Male; Masoprocol; Mice; Piperazines; Prostaglandin-Endoperoxide Synthases; Time Factors; Weight Gain	2008
Nordihydroguaiaretic acid protects against high-fat diet-induced fatty liver by activating AMP-activated protein kinase in obese mice. Biochemical and biophysical research communications, 2010, Oct-08, Volume: 401, Issue:1 Topics: Adiposity; AMP-Activated Protein Kinases; Animals; Diet; Dietary Fats; Fatty Liver; Hepatocytes; Insulin; Lipoxygenase Inhibitors; Male; Masoprocol; Mice; Mice, Inbred C57BL; Obesity; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Triglycerides; Weight Gain	2010

Article

Year

Conjugated linoleic acid-induced fat loss dependence on Delta6-desaturase or cyclooxygenase.

Obesity (Silver Spring, Md.), 2008, Volume: 16, Issue:10

Topics: Adipose Tissue; Adiposity; Animals; Aspirin; Cyclooxygenase Inhibitors; Dietary Fats; Dinoprostone; Eating; Enzyme Inhibitors; Leukotriene B4; Linoleic Acids, Conjugated; Linoleoyl-CoA Desaturase; Lipoxygenase; Lipoxygenase Inhibitors; Liver; Male; Masoprocol; Mice; Piperazines; Prostaglandin-Endoperoxide Synthases; Time Factors; Weight Gain

2008

Nordihydroguaiaretic acid protects against high-fat diet-induced fatty liver by activating AMP-activated protein kinase in obese mice.

Biochemical and biophysical research communications, 2010, Oct-08, Volume: 401, Issue:1

Topics: Adiposity; AMP-Activated Protein Kinases; Animals; Diet; Dietary Fats; Fatty Liver; Hepatocytes; Insulin; Lipoxygenase Inhibitors; Male; Masoprocol; Mice; Mice, Inbred C57BL; Obesity; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Triglycerides; Weight Gain

2010